News
Some recent news articles are listed below.
 Sense Proteomic Appoints The Sage Group to Develop Global Strategic Alliances in Novel Biomarkers for Oncology and Autoimmune Disease
Date: 04 Jan 2010Oxford UK – 18th December 2009 – Sense Proteomic Ltd. today announced the appointment of The Sage Group as its business development consultant to assist in expanding its global biomarker discovery partnerships. Sense is part ... Read entire article |
 The Sage Group Expands its Global Reach to Australia and Israel with New Executive Directors
Date: 18 Dec 2009Cambridge UK and Clinton USA – December 2009 – The Sage Group is pleased to announce the appointment of two new seasoned Executive Directors – Dr. Tom Geimer in Australia and Dr. Laurence Shaw in Israel. Drs. Geimer and... Read entire article |
 The Sage Group opens Israeli office with Appointment of Dr. Laurence Shaw as Executive Director
Date: 16 Dec 2009Cambridge UK and Clinton USA – December, 2009 – The Sage Group, Inc. is pleased to announce the expansion of its global network with the opening of an Israeli office and the appointment of Dr. Laurence Shaw as Executive Direc... Read entire article |
 The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate
Date: 27 May 2009Clinton, New Jersey, May 27, 2009 -- The Sage Group, a privately held international health care consulting group, announced today that HemispherX Biopharma has expanded the mandate for The Sage Group to include, in addition to the s... Read entire article |
 The Sage Group Strengthens US and EU Team with New Appointment of Mr. Glenn Kazo and Dr. Catherine Beech as Senior Directors
Date: 25 May 2009Cambridge UK and Bridgewater USA – May 2009 – The Sage Group is pleased to announce the appointment of two new Senior Directors – Mr. Glenn Kazo in the USA and Dr. Catherine Beech in the UK/EU. Mr. Kazo and Dr. B... Read entire article |
 Advaxis Explores New Drug Licensing Opportunities - The Sage Group to Help Introduce and Develop Potential Strategic Partnership Candidates
Date: 07 May 2009NORTH BRUNSWICK, N.J. 7th May 2009 --(BUSINESS WIRE)--Advaxis, Inc. (OTCBB: ADXS) has entered into a formal business agreement with the Sage Group to introduce potential partnership candidates and develop new licensing opportunities. ...Read entire article |
 ENKAM Pharmaceuticals Engages The Sage Group as Advisors on Global Strategic Partnering in Neuroscience and Cancer
Date: 28 Apr 2009Copenhagen and Cambridge, 28th April 2009 - ENKAM Pharmaceuticals A/S (“ENKAM” or “the Company”), the privately held biopharmaceutical development company focused on cancer and central nervous system disorders, is... Read entire article |
 OXFORD GENE TECHNOLOGY ACQUIRES SENSE PROTEOMIC LTD. TO DEVELOP BIOMARKER DISCOVERY BUSINESS
Date: 17 Mar 2009Oxford, UK, March 17, 2009 - Oxford Gene Technology (OGT) is pleased to announce the
acquisition of Sense Proteomic Ltd., a UK-based company engaged in the discovery of
disease-specific biomarkers based on its innovative fu... Read entire article |
 Merrion Pharmaceuticals Retains Sage Group to Augment Strategic Alliance Efforts
Date: 02 Feb 2009Dublin, Ireland, 2nd February 2009. Merrion Pharmaceuticals (IEX:MERR), an international specialty pharmaceutical company, today announced that it has retained The Sage Group to establish commercialisation partnerships for its Osteoporos... Read entire article |
 Cardio3 BioSciences Raises €13.7 million in Series B Fundraising
Date: 19 Jan 2009Mont-Saint-Guibert, Belgium, 19th January 2009... Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, has raised €7.2 million in a successfu... Read entire article | Older items are not shown...
|